CLOs on the Move


 
Anacor Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. It is based in Palo Alto, California, United States.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.anacor.com
  • 1020 E Meadow Cir
    Palo Alto, CA USA 94303
  • Phone: 650.543.7500

Executives

Name Title Contact Details

Similar Companies

NeoChord

NeoChord is a venture backed medical device company that has developed a proprietary device which allows mitral valve repair to be performed on a beating heart through a 2- to 3-inch incision between the ribs in patients with severe mitral valve regurgitation (MR). In contrast, most mitral valve repair procedures are performed through a 3 to 10 inch chest incision (sternotomy) that involves cutting through the sternum, opening the rib cage, stopping the heart and placing the patient on cardio-pulmonary bypass (CPB).

Inflexxion Inc

Inflexxion Inc is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Newton Upper Falls, MA. To find more information about Inflexxion Inc, please visit www.inflexxion.com

wi

Get hassle-free reproductive care for Herpes, BV, Yeast, UTI, Primary Care & Contraception. Same-day prescriptions picked up locally in a few hours or delivered FREE, discreetly packaged, to your home.

Blueprint Medicines

Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. Our ability to identify novel drivers of disease, coupled with our proprietary library of novel and diverse chemical compounds, uniquely enables us to craft kinase therapies against new and difficult-to-drug targets. We are boldly advancing a deep pipeline of highly targeted therapies against previously unaddressed drivers of disease. By focusing on genomically defined subsets of patients, we believe we can identify the people most likely to respond to our therapies, resulting in a more efficient clinical development path with a greater likelihood of success and better outcomes for patients. We see a substantial opportunity in kinase drug discovery and development to deliver breakthrough medicines that allow patients to live longer with better quality of life and prevent recurrences of disease. Kinases are involved in many hallmarks of tumor biology and are proven cancer drug targets. Currently approved drugs focus on less than 5 percent of known kinases, and the function of most kinases is unknown. Led by a team of industry innovators with a track record of bringing life-changing drugs to market, we believe Blueprint Medicines has the experience and expertise to deliver on the tremendous untapped potential of kinase therapies to improve patients’ lives. We don’t think in small steps. We think in giant leaps. We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.

Priority One Medical Transport

We provide priority care to many counties throughout Northern and Southern California. Please use the map to the right, or the list below to browse our service coverage. We provide priority care to many counties throughout Northern and Southern